Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Etanercept biosimilar approved in Japan

Jan. 22, 2018

FDA accepts Sandoz's BLA for adalimumab biosimilar

Jan. 16, 2018

KA34 to enter clinical testing for the treatment of osteoarthritis

Jan. 11, 2018

Galapagos reports topline results from phase Ib study of GLPG-1972 in osteoarthritis

Jan. 9, 2018

BioCryst Pharmaceuticals begins IND-enabling studies of two lead candidates

Jan. 9, 2018

Galapagos and Servier report ADAMTS inhibitors for osteoarthritis

Jan. 2, 2018

Patient recruitment ongoing in phase II trial of CR-6086

Dec. 29, 2017

Clover Biopharmaceuticals receives approval to initiate clinical trials of SCB-808 in China

Dec. 28, 2017

Phase II study of anabasum in SLE begins

Dec. 27, 2017

UCB reports phase IIb data on bimekizumab in psoriatic arthritis

Dec. 21, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...